Trial intelligence / Profile preview

Ketamine and Music for Suicidal Ideation

NCT04658420Phase 2Unknown

Sponsor
The University of Texas Health Science Center at Tyler
Start
Jul 2021
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ketamine in suicidal ideation (4 arms), sponsored by The University of Texas Health Science Center at Tyler. Primary endpoint: Scale for Suicide Ideation at 4 weeks. Status: unknown.

02

Drugs

ketamine
03

Conditions

suicidal ideation

Beyond the preview

Go deeper on NCT04658420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04658420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call